Point72 Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-26,600
| Closed | -$352K | – | 1785 |
|
|
2024
Q4 | $352K | Buy |
+26,600
| New | +$352K | ﹤0.01% | 1044 |
|
|
2024
Q2 | – | Sell |
-206,100
| Closed | -$2.86M | – | 1759 |
|
|
2024
Q1 | $2.86M | Buy |
+206,100
| New | +$2.86M | 0.01% | 816 |
|
|
2023
Q3 | – | Sell |
-2,125,500
| Closed | -$33.4M | – | 2155 |
|
|
2023
Q2 | $33.4M | Sell |
2,125,500
-403,297
| -16% | -$6.34M | 0.1% | 238 |
|
|
2023
Q1 | $41.7M | Sell |
2,528,797
-253,903
| -9% | -$4.18M | 0.13% | 189 |
|
|
2022
Q4 | $43.4M | Buy |
+2,782,700
| New | +$43.4M | 0.15% | 175 |
|
|
2021
Q4 | – | Sell |
-1,299,900
| Closed | -$21.3M | – | 1220 |
|
|
2021
Q3 | $21.3M | Sell |
1,299,900
-77,100
| -6% | -$1.26M | 0.09% | 273 |
|
|
2021
Q2 | $23.2M | Buy |
+1,377,000
| New | +$23.2M | 0.1% | 237 |
|
|
2021
Q1 | – | Sell |
-651,300
| Closed | -$11.9M | – | 1118 |
|
|
2020
Q4 | $11.9M | Buy |
+651,300
| New | +$11.9M | 0.06% | 382 |
|
|
2019
Q4 | – | Sell |
-267,562
| Closed | -$4.6M | – | 1185 |
|
|
2019
Q3 | $4.6M | Buy |
+267,562
| New | +$4.6M | 0.03% | 439 |
|
|
2019
Q2 | – | Sell |
-976,514
| Closed | -$19.9M | – | 1402 |
|
|
2019
Q1 | $19.9M | Buy |
+976,514
| New | +$19.9M | 0.09% | 219 |
|